Position switch of phenylthiazoles: novel compounds with promising anti-MRSA USA300
Medicinal Chemistry Research(2024)
Abstract
The discovery of novel antibacterial agents holds promise in mitigating the escalating threat of antimicrobial resistance (AMR). Guided by the structure-activity relationships (SAR) of our lead compound 1 against MRSA, we developed novel anti-MRSA compounds with a repositioned lipophilic tail from para to meta position. This strategic modification resulted in compounds 10e and 10l exhibiting equivalent activity to lead compound 1 (MIC = 4 µg/ml) against the highly clinically important strain MRSA USA300. Additionally, both compounds demonstrated a low propensity for resistance development and an acceptable cytotoxicity profile. However, their systemic administration was poorly tolerated. The in vivo study in a murine model revealed modest activity in the skin model but an acceptable effect in controlling systemic dissemination.
MoreTranslated text
Key words
Antibiotic resistance,Phenylthiazole,Methicillin-resistant Staphylococcus aureus (MRSA)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined